214 related articles for article (PubMed ID: 26586342)
1. Dissolution enhancement of active pharmaceutical ingredients by therapeutic deep eutectic systems.
Aroso IM; Silva JC; Mano F; Ferreira AS; Dionísio M; Sá-Nogueira I; Barreiros S; Reis RL; Paiva A; Duarte AR
Eur J Pharm Biopharm; 2016 Jan; 98():57-66. PubMed ID: 26586342
[TBL] [Abstract][Full Text] [Related]
2. A comparison between pure active pharmaceutical ingredients and therapeutic deep eutectic solvents: Solubility and permeability studies.
Duarte AR; Ferreira AS; Barreiros S; Cabrita E; Reis RL; Paiva A
Eur J Pharm Biopharm; 2017 May; 114():296-304. PubMed ID: 28189620
[TBL] [Abstract][Full Text] [Related]
3. Design of controlled release systems for THEDES-Therapeutic deep eutectic solvents, using supercritical fluid technology.
Aroso IM; Craveiro R; Rocha Â; Dionísio M; Barreiros S; Reis RL; Paiva A; Duarte AR
Int J Pharm; 2015 Aug; 492(1-2):73-9. PubMed ID: 26142248
[TBL] [Abstract][Full Text] [Related]
4. Eutectic solutions for healing: a comprehensive review on therapeutic deep eutectic solvents (TheDES).
Kalantri S; Vora A
Drug Dev Ind Pharm; 2024 May; 50(5):387-400. PubMed ID: 38634708
[TBL] [Abstract][Full Text] [Related]
5. Selecting Excipients Forming Therapeutic Deep Eutectic Systems-A Mechanistic Approach.
Wolbert F; Brandenbusch C; Sadowski G
Mol Pharm; 2019 Jul; 16(7):3091-3099. PubMed ID: 31095911
[TBL] [Abstract][Full Text] [Related]
6. Evaporation Behavior and Characterization of Eutectic Solvent and Ibuprofen Eutectic Solution.
Phaechamud T; Tuntarawongsa S; Charoensuksai P
AAPS PharmSciTech; 2016 Oct; 17(5):1213-20. PubMed ID: 26669887
[TBL] [Abstract][Full Text] [Related]
7. Properties of Therapeutic Deep Eutectic Solvents of l-Arginine and Ethambutol for Tuberculosis Treatment.
Santos F; P S Leitão MI; C Duarte AR
Molecules; 2018 Dec; 24(1):. PubMed ID: 30586896
[TBL] [Abstract][Full Text] [Related]
8. Pharmaceutical applications of therapeutic deep eutectic systems (THEDES) in maximising drug delivery.
Javed S; Mangla B; Sultan MH; Almoshari Y; Sivadasan D; Alqahtani SS; Madkhali OA; Ahsan W
Heliyon; 2024 May; 10(9):e29783. PubMed ID: 38694051
[TBL] [Abstract][Full Text] [Related]
9. Formulation of Ascorbic Acid and Betaine-based Therapeutic Deep Eutectic System for Enhanced Transdermal Delivery of Ascorbic Acid.
Song JE; Jun SH; Ryoo JY; Kang NG
Pharmaceutics; 2024 May; 16(5):. PubMed ID: 38794349
[TBL] [Abstract][Full Text] [Related]
10. Solids Turn into Liquids-Liquid Eutectic Systems of Pharmaceutics to Improve Drug Solubility.
Sarraguça MC; Ribeiro PRS; Nunes C; Seabra CL
Pharmaceuticals (Basel); 2022 Feb; 15(3):. PubMed ID: 35337077
[TBL] [Abstract][Full Text] [Related]
11. Deep eutectic solvents comprising active pharmaceutical ingredients in the development of drug delivery systems.
Pedro SN; Freire MG; Freire CSR; Silvestre AJD
Expert Opin Drug Deliv; 2019 May; 16(5):497-506. PubMed ID: 30955386
[TBL] [Abstract][Full Text] [Related]
12. Investigation on drug solubility enhancement using deep eutectic solvents and their derivatives.
Li Z; Lee PI
Int J Pharm; 2016 May; 505(1-2):283-8. PubMed ID: 27079143
[TBL] [Abstract][Full Text] [Related]
13. Characterization of thermal behavior of deep eutectic solvents and their potential as drug solubilization vehicles.
Morrison HG; Sun CC; Neervannan S
Int J Pharm; 2009 Aug; 378(1-2):136-9. PubMed ID: 19477257
[TBL] [Abstract][Full Text] [Related]
14. Production of Electrospun Fast-Dissolving Drug Delivery Systems with Therapeutic Eutectic Systems Encapsulated in Gelatin.
Mano F; Martins M; Sá-Nogueira I; Barreiros S; Borges JP; Reis RL; Duarte ARC; Paiva A
AAPS PharmSciTech; 2017 Oct; 18(7):2579-2585. PubMed ID: 28236268
[TBL] [Abstract][Full Text] [Related]
15. Development of Polycaprolactone-Based metronidazole matrices for intravaginal extended drug delivery using a mechanochemically prepared therapeutic deep eutectic system.
Li S; Culkin A; Jones DS; Andrews GP
Int J Pharm; 2021 Jan; 593():120071. PubMed ID: 33246048
[TBL] [Abstract][Full Text] [Related]
16. A choline chloride-acrylic acid deep eutectic solvent polymer based on Fe
Fu N; Li L; Liu K; Kim CK; Li J; Zhu T; Li J; Tang B
Talanta; 2019 May; 197():567-577. PubMed ID: 30771977
[TBL] [Abstract][Full Text] [Related]
17. Solubility of pharmaceutical ingredients in triglycerides.
Brinkmann J; Huxoll F; Luebbert C; Sadowski G
Eur J Pharm Biopharm; 2019 Dec; 145():113-120. PubMed ID: 31682903
[TBL] [Abstract][Full Text] [Related]
18. Stabilizing Unstable Amorphous Menthol through Inclusion in Mesoporous Silica Hosts.
Cordeiro T; Castiñeira C; Mendes D; Danède F; Sotomayor J; Fonseca IM; Gomes da Silva M; Paiva A; Barreiros S; Cardoso MM; Viciosa MT; Correia NT; Dionisio M
Mol Pharm; 2017 Sep; 14(9):3164-3177. PubMed ID: 28836790
[TBL] [Abstract][Full Text] [Related]
19. Eutectic-based liposome as a potential delivery system of paeonol.
Wu J; Yang S; Yin T; Wang X
RSC Adv; 2021 Dec; 11(62):39343-39348. PubMed ID: 35492495
[TBL] [Abstract][Full Text] [Related]
20. Tailor-made solvents for pharmaceutical use? Experimental and computational approach for determining solubility in deep eutectic solvents (DES).
Palmelund H; Andersson MP; Asgreen CJ; Boyd BJ; Rantanen J; Löbmann K
Int J Pharm X; 2019 Dec; 1():100034. PubMed ID: 31993583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
